Trailing-twelve-month (TTM) revenue is $230.72 Million with a year-over-year growth of +17.31%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from CAD to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $47,878,394 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q3 FY2026Period ended 2025-12-31 | $74,480,254 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q4 FY2026Period ended 2026-03-31 | $51,219,455 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-15 |
| Q1 FY2027Period ended 2026-06-30 | $57,140,160 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $230,718,263 |
Current P/S: $373,396,002 market capitalization ÷ $230,718,263 TTM revenue = 1.62x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $57.14M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:50:58.391Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · CAD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · CAD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · CAD | FY20222022-03-31 · CAD | FY20232023-03-31 · CAD | FY20242024-03-31 · CAD | FY20252025-03-31 · CAD | FY20262026-03-31 · CAD |
|---|---|---|---|---|---|---|
| Canadian Cannabis Net Revenue | CAD 285M | CAD 258M | N/A | N/A | CAD 156M | N/A |
| Canadian Medical Cannabis Net Revenue | CAD 55M | CAD 53M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · CAD | FY20222022-03-31 · CAD | FY20232023-03-31 · CAD | FY20242024-03-31 · CAD | FY20252025-03-31 · CAD | FY20262026-03-31 · CAD |
|---|---|---|---|---|---|---|
| CANADA | N/A | N/A | CAD 268M | N/A | N/A | CAD 186M |
| Canadian Cannabis Net Revenue | N/A | N/A |
$230.72M
$230.72 Million
+17.31%
vs. $196.67M a year ago (TTM)
(12.47%)
5 Year compound annual growth rate
1 Year
+17.31%
3 Year
+0.78%
5 Year
(12.47%)
10 Year
+32.69%
15 Year
+104.37%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $204.61M | +$17.70M | +9.47% |
| 2025 | $186.91M | ($32.84M) | (14.95%) |
| 2024 | $219.75M | ($26.66M) | (10.82%) |
| 2023 | $246.41M | ($133.77M) | (35.19%) |
| 2022 | $380.18M | ($54.86M) | (12.61%) |
| 2021 |
TTM Growth
+17.31%
3-Year CAGR
+0.78%
5-Year CAGR
(12.47%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 39 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T12:50:58.391Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| N/A |
| Canadian Recreational Cannabis Net Revenue | CAD 230M | CAD 205M | N/A | N/A | N/A | N/A |
|---|
| Consumer Products And Other | CAD 168M | CAD 183M | N/A | N/A | N/A | N/A |
|---|
| Global Cannabis Net Revenue | CAD 379M | CAD 337M | N/A | N/A | N/A | N/A |
|---|
| International And Other Revenue | CAD 62M | CAD 36M | N/A | N/A | CAD 40M | N/A |
|---|
| Other Revenue | N/A | N/A | CAD 16M | CAD 10M | CAD 0 | CAD 0 |
|---|
| Storz And Bickel | N/A | N/A | N/A | N/A | CAD 73M | N/A |
|---|
| N/A |
| CAD 156M |
| N/A |
| GERMANY | CAD 116M | CAD 91M | N/A | CAD 52M | N/A | CAD 62M |
|---|
| International And Other Revenue | N/A | N/A | N/A | N/A | CAD 40M | N/A |
|---|
| Other Geographical Area | CAD 36M | CAD 51M | N/A | CAD 41M | N/A | CAD 8M |
|---|
| Other Revenue | N/A | N/A | N/A | N/A | CAD 0 | N/A |
|---|
| Storz And Bickel | N/A | N/A | N/A | N/A | CAD 73M | N/A |
|---|
| UNITED STATES | CAD 65M | CAD 82M | N/A | CAD 41M | N/A | N/A |
|---|
| USA | N/A | N/A | N/A | N/A | N/A | CAD 28M |
|---|
| $435.04M |
| +$151.68M |
| +53.53% |
| 2020 | $283.36M | +$113.77M | +67.09% |
| 2019 | $169.58M | +$109.16M | +180.65% |
| 2018 | $60.43M | +$30.46M | +101.65% |
| 2017 | $29.97M | +$20.19M | +206.49% |
